Preclinical efficacy and safety assessment of engineered regulatory T cells for treatment of IPEX and other autoimmune disorders. - Honaker Y; Dahl NP; Singh S; Singh AK; Lopez C; Gruber D; Scharffenberger SC; Patel S; Jones H; Khan IF; Christian ML; Yang SJ; et al. (Molecular therapy : the journal of the American Society of Gene Therapy, 2026)